The FDA approved tavapadon (Juvmo), a new once-daily Parkinson’s medication, on September 25, 2026. It helps manage movement symptoms, including tremors, stiffness, and slowed movement.
Clinical trials showed improvements in daily functioning and symptom control, offering another treatment option for adults living with Parkinson’s disease.
While tavapadon is not a cure, its approval represents meaningful progress for individuals and families navigating this condition.
Key Takeaways About Tavapadon
- New treatment option: Tavapadon is an FDA-approved, once-daily prescription medication for adults with Parkinson’s.
- Improved movement: Clinical trials demonstrated benefits for movement symptoms and everyday activities.
- Additional symptom control: When added to levodopa, tavapadon provided approximately one additional hour of daily symptom control without troublesome involuntary movements compared with placebo.
- Potential side effects: Nausea, dizziness, low blood pressure, and hallucinations are among the concerns families should discuss with a neurologist.
- Individualized treatment: Tavapadon may benefit some individuals, but medication decisions depend on personal health needs and existing treatments.
Tavapadon vs. Levodopa: What Is the Difference?
Both medications help manage Parkinson’s movement symptoms, but they work differently.
| Tavapadon (Juvmo) | Levodopa |
| Mimics dopamine by activating specific brain receptors | Is converted into dopamine in the brain |
| Taken once daily | Dosing varies by formulation and treatment plan |
| Can be used alone or alongside levodopa | Commonly used as a foundational Parkinson’s treatment |
Tavapadon does not replace levodopa for everyone. Instead, it expands the treatment options neurologists can consider when symptoms are not adequately controlled.
Need Support Navigating Parkinson’s Care?
At The Kensington Reston, we understand that managing Parkinson’s involves more than medication. Personalized support, dependable routines, and compassionate care can make everyday life more manageable.
Our team is here to help your family explore care options as your loved one’s needs change.
Explore Parkinson’s Care at The Kensington Reston
How Does the New Parkinson’s Drug Tavapadon Work?
Parkinson’s disease affects brain cells that produce dopamine, a chemical essential for controlling movement.
As dopamine levels decrease, everyday activities can become more challenging.
Your loved one may experience:
- Tremors in the hands, arms, or legs
- Muscle stiffness
- Slower walking or movement
- Difficulty initiating movement
- Changes in balance and coordination
Tavapadon belongs to a medication class called dopamine agonists, which mimic dopamine’s effects in the brain.
What Makes Tavapadon Different?
Unlike earlier dopamine agonists, tavapadon selectively activates two dopamine receptors, D1 and D5, which help regulate movement.
This targeted approach has two potential advantages:
- More selective action: Tavapadon focuses on dopamine receptors involved in movement rather than activating the broader range of receptors targeted by older dopamine agonists.
- Potential for fewer side effects: Its selectivity may reduce certain unwanted effects associated with other dopamine agonists, although this has not been proven in direct comparisons.
What families should know: Tavapadon represents a different approach within an established medication class. According to The Michael J. Fox Foundation, ongoing research is examining its longer-term safety and effectiveness.
For more information about how Parkinson’s symptoms and care needs may change, explore our guide to navigating a Parkinson’s diagnosis.
What Did Tavapadon Clinical Trials Reveal?
The FDA’s approval was supported by the Phase III TEMPO clinical trial program.
These studies evaluated tavapadon in people with early Parkinson’s and those experiencing symptoms despite existing medication.
Benefits for Early Parkinson’s Disease
The TEMPO-1 and TEMPO-2 trials studied individuals with earlier Parkinson’s who were not taking dopamine medications such as levodopa.
Compared with placebo, tavapadon improved movement symptoms and the ability to manage everyday activities.
These included:
- Dressing and personal grooming
- Eating independently
- Managing personal hygiene
- Completing other routine activities
For someone experiencing stiffness or slowed movement, improvements in these activities can be meaningful.
However, individual results vary. Not everyone will experience the same level of benefit.
Benefits When Added to Levodopa
The TEMPO-3 trial evaluated tavapadon in individuals already taking levodopa who experienced fluctuations in symptom control.
After 26 weeks, participants taking tavapadon alongside levodopa experienced:
- Approximately 1.7 additional hours of daily on time without troublesome dyskinesia, compared with 0.6 hours in the placebo group.
- A reduction in daily off time of approximately 1.9 hours, compared with 0.9 hours in the placebo group.
In other words, tavapadon provided approximately one additional hour of better symptom control compared with placebo.
What Do On Time and Off Time Mean?
- On time refers to periods when Parkinson’s medication is working well, and movement symptoms are better controlled.
- Off time occurs when medication effects wear off, allowing symptoms such as stiffness, tremors, or slowed movement to return.
Dyskinesia refers to involuntary movements that can sometimes occur with Parkinson’s treatment.
For a loved one who experiences unpredictable off periods, additional time with better movement control may make daily routines easier.
These findings are encouraging, but they do not mean every person taking tavapadon will gain an additional hour of symptom relief.
What Are Tavapadon’s Side Effects and Risks?
Like other Parkinson’s medications, tavapadon can cause side effects.
Clinical trials identified several common reactions, including:
- Nausea
- Headache
- Dizziness
- Fatigue
Among individuals taking tavapadon alongside levodopa, additional reported reactions included:
- Dyskinesia: Involuntary movements
- Orthostatic hypotension: A drop in blood pressure when standing
- Hallucinations: Seeing, hearing, or sensing things that are not present
Tavapadon can also cause or worsen compulsive behaviors, such as excessive shopping, eating, or gambling.
Families should also remain alert to unusual sleepiness or changes in behavior.
Why These Risks Matter for Older Adults
Dizziness and sudden changes in blood pressure can increase fall risk, particularly for individuals who already have balance difficulties.
Hallucinations or behavioral changes may also affect daily safety and well-being.
If your loved one begins tavapadon, pay attention to changes in:
- Balance and walking
- Alertness and sleep patterns
- Mood or behavior
- Perception and thinking
- Involuntary movements
Report concerning changes promptly to the prescribing clinician.
Because Parkinson’s can involve symptoms beyond movement, families may benefit from understanding non-motor symptoms of Parkinson’s disease.
Is Tavapadon Right for Your Loved One?
A new medication can bring hope, especially when your loved one experiences symptoms that interfere with daily life.
However, the most appropriate treatment depends on individual circumstances.
A neurologist may consider:
- Current symptoms and their severity
- How well existing medications work
- Previous medication side effects
- Other health conditions
- Personal goals for daily functioning
If your loved one’s current treatment is effective, changes may not be necessary.
If symptoms remain difficult to control, discussing tavapadon may help identify additional options.
Five Questions to Ask the Neurologist
Bring these questions to your loved one’s next appointment:
- Could tavapadon improve their current movement symptoms?
- Can it be safely combined with their existing medications?
- Which side effects should our family monitor?
- How will we know whether the treatment is working?
- What other treatment or supportive care options should we consider?
It may also help to keep a daily symptom journal.
Record medication times, periods of better movement, and any new concerns. These details can help the neurologist evaluate treatment effectiveness.
Never start, stop, or adjust Parkinson’s medication without guidance from the prescribing clinician.
How Personalized Parkinson’s Care Supports Everyday Life
Medication is an important part of Parkinson’s treatment, but it does not address every challenge associated with the condition. Changes in movement, fatigue, communication difficulties, and other symptoms can affect a loved one’s independence.
At The Kensington Reston, we recognize that care needs are personal and may evolve over time.
Our approach combines individualized assistance with attentive nursing, rehabilitation services, and family involvement.
Nursing Support and Medication Management
Managing Parkinson’s often involves adhering to specific medication schedules and monitoring symptom changes.
At The Kensington Reston:
- Licensed nurses are on-site 24 hours a day and administer medication.
- Registered nurses coordinate residents’ nursing and medical care.
Our team also works with residents and their healthcare providers to support individualized care plans.
This continuity is particularly important when symptoms or care requirements change.
Physical, Occupational, and Speech Therapy
Parkinson’s may affect walking, balance, communication, and the ability to complete everyday tasks.
Our community offers physical, occupational, and speech therapy services to address individual needs.
These services may focus on:
- Physical therapy: Balance, strength, mobility, and safe movement
- Occupational therapy: Daily activities such as dressing, grooming, and eating
- Speech therapy: Communication, voice strength, and swallowing concerns
Therapy recommendations depend on each resident’s abilities, health, and treatment goals.
Encouraging Independence and Meaningful Daily Living
Living with Parkinson’s does not mean giving up personal interests, preferences, or opportunities for connection.
At The Kensington Reston, we encourage residents to remain involved in daily life while receiving assistance when needed.
Our approach prioritizes:
- Respecting personal routines and preferences
- Supporting independence with appropriate assistance
- Encouraging social connection and engagement
- Adjusting care as needs evolve
The goal is to provide the right support while honoring what they can and want to do independently.
Helping Families Navigate Changing Needs
A Parkinson’s diagnosis can gradually change family responsibilities. Spouses and adult children may begin coordinating appointments, managing medications, or assisting with personal care.
At The Kensington Reston, we understand the importance of keeping families informed and involved. Our team members build relationships with residents and loved ones to better understand their preferences, concerns, and goals.
For families considering additional support, our personalized assisted living services provide a closer look at how we help residents navigate changing care needs.
Explore Personalized Parkinson’s Support
Has your loved one begun needing more help with mobility, medication routines, or everyday activities?
Our team at The Kensington Reston welcomes the opportunity to learn about your family’s situation and discuss available care options.
Speak with Our Team About Parkinson’s Care
FAQs: New Parkinson’s Drug Tavapadon
No. Tavapadon treats Parkinson’s symptoms but does not cure the disease or stop its progression. Its purpose is to improve movement control and help individuals manage daily activities.
Yes. Clinical trials studied tavapadon independently and in combination with levodopa. A neurologist can determine whether adding it to an existing treatment plan is appropriate.
Tavapadon may be an option for some older adults, but safety depends on individual health factors. Dizziness, blood pressure changes, hallucinations, and involuntary movements require particular attention. A prescribing clinician should review potential risks and medication interactions before treatment begins.
AbbVie announced that Juvmo was expected to become available in the United States in October 2026. Because pharmacy availability and insurance coverage may vary, families should confirm current access with their neurologist, pharmacist, or insurance provider.
Moving Forward with Hope and Personalized Parkinson’s Care
Tavapadon represents encouraging progress in Parkinson’s treatment, offering another option for managing movement symptoms.
For families, the most important next step is understanding whether this medication fits their loved one’s needs.
At The Kensington Reston, we believe quality care goes beyond managing symptoms. It means respecting each resident’s individuality, supporting independence, and helping families navigate change with confidence.
Discover Compassionate Parkinson’s Care at The Kensington Reston
Whether your loved one was recently diagnosed or has been living with Parkinson’s for years, our team is here to listen and help you explore personalized support.
We invite you to visit our community, meet our team members, and see how our approach to care can support your family.
Schedule a Private Tour of The Kensington Reston
This article provides general educational information and does not replace medical advice. Consult your loved one’s neurologist or prescribing clinician before making treatment decisions.